{"protocolSection": {"identificationModule": {"nctId": "NCT01286129", "orgStudyIdInfo": {"id": "FP-2005-3"}, "secondaryIdInfos": [{"id": "CER1223", "type": "OTHER", "domain": "Ethics committee"}], "organization": {"fullName": "Laval University", "class": "OTHER"}, "briefTitle": "Nasal Allergen Challenge in Rhinitic Subjects", "officialTitle": "Comparative Responses to Nasal Allergen Challenge in Allergic Rhinitic Subjects With or Without Asthma"}, "statusModule": {"statusVerifiedDate": "2019-01", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2005-11"}, "primaryCompletionDateStruct": {"date": "2008-03", "type": "ACTUAL"}, "completionDateStruct": {"date": "2008-03", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-01-13", "studyFirstSubmitQcDate": "2011-01-27", "studyFirstPostDateStruct": {"date": "2011-01-31", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2012-03-29", "resultsFirstSubmitQcDate": "2013-05-24", "resultsFirstPostDateStruct": {"date": "2013-07-01", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2019-01-15", "lastUpdatePostDateStruct": {"date": "2019-02-01", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Laval University", "class": "OTHER"}, "collaborators": [{"name": "AllerGen NCE Inc.", "class": "INDUSTRY"}]}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Background: Nasal allergen challenge (NAC) is useful to study the pathophysiology of rhinitis, and multiple challenges may more adequately approximate natural exposure.\n\nObjective: To determine the effect of 4 consecutive daily NAC, on clinical and inflammatory parameters in rhinitics with or without asthma.", "detailedDescription": "The study will be performed outside the pollen season. On a baseline visit, 2 to 7 days prior to control challenge, allergy skin prick tests and methacholine inhalation test will be done. Prior to first allergen challenge, skin titration will be done using tenfold dilutions of the allergen chosen for nasal challenges. Subsequent to baseline visit, a control challenge will be done, followed, a week later, by repeated NACs. NACs will be done over 4 consecutive days, in the morning. Nasal peak inspiratory flows (NPIF), oral peak expiratory flows (PEF), and symptoms will be recorded at baseline and at regular intervals over 7 hours post-challenge on each challenge day. Induced sputum and nasal lavage specimen will be obtained 7 hours following the control challenge and the first and last NAC."}, "conditionsModule": {"conditions": ["Asthma", "Allergic Rhinitis"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "NON_RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "PREVENTION", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 45, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Allergic asthmatic", "type": "ACTIVE_COMPARATOR", "description": "Subjects with allergic asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.", "interventionNames": ["Procedure: Nasal allergen challenge"]}, {"label": "Allergic rhinitic without asthma", "type": "ACTIVE_COMPARATOR", "description": "Subjects with allergic rhinitis without asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.", "interventionNames": ["Procedure: Nasal allergen challenge"]}], "interventions": [{"type": "PROCEDURE", "name": "Nasal allergen challenge", "description": "Allergen sprayed into nostrils. Allergen used will be house dust mite or cat allergen. Allergens will be given in increasing ten-fold dilutions until a positive response occurs.", "armGroupLabels": ["Allergic asthmatic", "Allergic rhinitic without asthma"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change in Sputum Eosinophils Following Allergen Challenge", "description": "Eosinophil is an inflammatory cell found in the lungs. Sputum is obtained from hypertonic inhalation. patients expectorate in a sterile dish and mucus plugs are selected and treated to obtain cells. cells are transferred on a slide and a differential count is obtained where eosinophils are counted.", "timeFrame": "At 7 hours post first and last challenge compared to baseline"}], "secondaryOutcomes": [{"measure": "Change in Nasal Lavage Eosinophils After Allergen Challenge", "description": "Change in nasal lavage eosinophil percentages in allergic asthmatic and allergic non asthmatic at baseline and at 7h post first and last challenge", "timeFrame": "At 7 hours post first and last challenge compared to baseline"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* To have a positive reaction to one or more allergen on prick tests.\n* Non smokers\n* No respiratory track infection for at least one month prior to the study.\n* Positive reaction to cat hair and/or house dust mite (Dermatophagoides pteronyssinus) aeroallergens on allergy skin prick tests and report rhinitis symptoms when exposed to an environment containing this allergen.\n* Asthmatic subjects using only inhaled beta-2 agonists on an as needed basis for their asthma treatment.\n* Asthmatic subjects with a history of asthma of at least 6 months.\n* Asthmatic subjects with PC20 methacholine lower or equal to 8 mg/ml.\n* Allergic rhinitic subjects never experienced any asthma symptoms or took any asthma medication in the past.\n* Allergic rhinitic subjects with a provocative concentration of methacholine (PC20 higher than 16 mg/ml.\n\nExclusion Criteria:\n\n* Smokers or ex smokers less than 6 months or more than 10 pack-years.\n* Asthmatic subjects using or used in the past 3 months inhaled or oral corticosteroids.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "45 Years", "stdAges": ["ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Louis-Philippe Boulet, MD", "affiliation": "Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec, University Laval", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Qu\u00e9bec", "city": "Qu\u00e9bec", "state": "Quebec", "zip": "G1V 4G5", "country": "Canada", "geoPoint": {"lat": 46.81228, "lon": -71.21454}}]}, "referencesModule": {"references": [{"pmid": "21507261", "type": "DERIVED", "citation": "Rousseau MC, Boulay ME, Goronfolah L, Denburg J, Keith P, Boulet LP. Comparative responses to nasal allergen challenge in allergic rhinitic subjects with or without asthma. Allergy Asthma Clin Immunol. 2011 Apr 20;7(1):8. doi: 10.1186/1710-1492-7-8."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "After enrollment, there was a one to 7 days run-in period. Subjects that could not produce a quality sputum sample were excluded from the trial.", "recruitmentDetails": "Subjects were recruited from advertisement between November 2005 and october 2008", "groups": [{"id": "FG000", "title": "Allergic Asthmatic", "description": "Subjects with allergic asthma will undergo nasal allergen provocations with either house dust mite or cat pelt."}, {"id": "FG001", "title": "Allergic Rhinitic Without Asthma", "description": "Subjects with allergic rhinitis without asthma will undergo nasal allergen provocations with either house dust mite or cat pelt."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "27"}, {"groupId": "FG001", "numSubjects": "18"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "19"}, {"groupId": "FG001", "numSubjects": "13"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "8"}, {"groupId": "FG001", "numSubjects": "5"}]}], "dropWithdraws": [{"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Could not comply with study requirements", "reasons": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "4"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Allergic Asthmatic", "description": "Subjects with allergic asthma will undergo nasal allergen provocations with either house dust mite or cat pelt."}, {"id": "BG001", "title": "Allergic Rhinitic Without Asthma", "description": "Subjects with allergic rhinitis without asthma will undergo nasal allergen provocations with either house dust mite or cat pelt."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "27"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "45"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "27"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "45"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "24", "spread": "4"}, {"groupId": "BG001", "value": "24", "spread": "7"}, {"groupId": "BG002", "value": "24", "spread": "5"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "20"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "28"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "7"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "17"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "Canada", "categories": [{"measurements": [{"groupId": "BG000", "value": "27"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "45"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change in Sputum Eosinophils Following Allergen Challenge", "description": "Eosinophil is an inflammatory cell found in the lungs. Sputum is obtained from hypertonic inhalation. patients expectorate in a sterile dish and mucus plugs are selected and treated to obtain cells. cells are transferred on a slide and a differential count is obtained where eosinophils are counted.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage of sputum eosinophils", "timeFrame": "At 7 hours post first and last challenge compared to baseline", "groups": [{"id": "OG000", "title": "Allergic Asthmatic", "description": "Subjects with allergic asthma will undergo nasal allergen provocations with either house dust mite or cat pelt."}, {"id": "OG001", "title": "Allergic Rhinitic Without Asthma", "description": "Subjects with allergic rhinitis without asthma will undergo nasal allergen provocations with either house dust mite or cat pelt."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "13"}]}], "classes": [{"title": "Baseline percentage eosinophils", "categories": [{"measurements": [{"groupId": "OG000", "value": "5.6", "spread": "1.8"}, {"groupId": "OG001", "value": "2.0", "spread": "1.3"}]}]}, {"title": "7h post first challenge percentage eosinophils", "categories": [{"measurements": [{"groupId": "OG000", "value": "6.0", "spread": "1.7"}, {"groupId": "OG001", "value": "1.3", "spread": "1.5"}]}]}, {"title": "7h post last challenge percentage eosinophils", "categories": [{"measurements": [{"groupId": "OG000", "value": "4.1", "spread": "1.4"}, {"groupId": "OG001", "value": "1.6", "spread": "1.0"}]}]}]}, {"type": "SECONDARY", "title": "Change in Nasal Lavage Eosinophils After Allergen Challenge", "description": "Change in nasal lavage eosinophil percentages in allergic asthmatic and allergic non asthmatic at baseline and at 7h post first and last challenge", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "percentage of nasal lavage eosinophils", "timeFrame": "At 7 hours post first and last challenge compared to baseline", "groups": [{"id": "OG000", "title": "Allergic Asthmatic", "description": "Change in nasal lavage eosinophil percentages in allergic asthmatic at baseline and at 7h post first and last challenge"}, {"id": "OG001", "title": "Allergic Non Asthmatic", "description": "Change in nasal lavage eosinophil percentages in allergic non asthmatic at baseline and at 7h post first and last challenge"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "13"}]}], "classes": [{"title": "Baseline percentage eosinophils", "categories": [{"measurements": [{"groupId": "OG000", "value": "2.1", "spread": "0.6"}, {"groupId": "OG001", "value": "1.3", "spread": "0.9"}]}]}, {"title": "7h post first challenge percentage eosinophils", "categories": [{"measurements": [{"groupId": "OG000", "value": "7.5", "spread": "4.3"}, {"groupId": "OG001", "value": "3.0", "spread": "1.3"}]}]}, {"title": "7h post last challenge percentage eosinophils", "categories": [{"measurements": [{"groupId": "OG000", "value": "15.7", "spread": "5.4"}, {"groupId": "OG001", "value": "15.5", "spread": "9.6"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "eventGroups": [{"id": "EG000", "title": "Allergic Asthmatic", "description": "Subjects with allergic asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.", "seriousNumAffected": 0, "seriousNumAtRisk": 19, "otherNumAffected": 0, "otherNumAtRisk": 19}, {"id": "EG001", "title": "Allergic Rhinitic Without Asthma", "description": "Subjects with allergic rhinitis without asthma will undergo nasal allergen provocations with either house dust mite or cat pelt.", "seriousNumAffected": 0, "seriousNumAtRisk": 13, "otherNumAffected": 0, "otherNumAtRisk": 13}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Louis-Philippe Boulet, principal investigator", "organization": "IUCPQ", "email": "lpboulet@med.ulaval.ca", "phone": "418-656-4747"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000012220", "term": "Rhinitis"}, {"id": "D000001249", "term": "Asthma"}, {"id": "D000065631", "term": "Rhinitis, Allergic"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}, {"id": "D000012141", "term": "Respiratory Tract Infections"}, {"id": "D000007239", "term": "Infections"}, {"id": "D000009668", "term": "Nose Diseases"}, {"id": "D000010038", "term": "Otorhinolaryngologic Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M15049", "name": "Rhinitis", "asFound": "Rhinitis", "relevance": "HIGH"}, {"id": "M30545", "name": "Rhinitis, Allergic", "asFound": "Allergic Rhinitis", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}, {"id": "M10283", "name": "Infections", "relevance": "LOW"}, {"id": "M6368", "name": "Communicable Diseases", "relevance": "LOW"}, {"id": "M14978", "name": "Respiratory Tract Infections", "relevance": "LOW"}, {"id": "M12604", "name": "Nose Diseases", "relevance": "LOW"}, {"id": "M12961", "name": "Otorhinolaryngologic Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC01", "name": "Infections"}, {"abbrev": "BC09", "name": "Ear, Nose, and Throat Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}]}}, "hasResults": true}